Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Jazz Pharmaceuticals PLC    JAZZ   IE00B4Q5ZN47

Delayed Quote. Delayed  - 08/26 10:00:00 pm
128.52 USD   +0.91%
08/09 JAZZ PHARMACEUT : Announces Second Quarter 2016 Financial Results
08/03 JAZZ PHARMACEUT : CMS Grants New Technology Add-On Payment to Defite..
07/28 JAZZ PHARMACEUT : and Pfenex Enter into a Worldwide License and Opti..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Jazz Pharmaceuticals PLC
Operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products.

The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry.

Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded on January 18, 2012 and is headquartered in Dublin, Ireland.

Number of employees : 910 persons.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Pharmaceutical Products1,173100%1,325100% +12.95%
Sales per Regions
20142015Delta
USD (in Million)%USD (in Million)%
United States1,00785.9%1,19390% +18.41%
Europe126.7210.8%103.617.8% -18.23%
All Other38.763.3%28.312.1% -26.97%
Managers
NameAgeSinceTitle
Bruce C. Cozadd, MBA522012Chairman & Chief Executive Officer
Russell J. Cox532012Chief Operating Officer & Executive Vice President
Matthew P. Young, MBA472013Chief Financial Officer & Executive Vice President
Mark G. Eller, PhD-2012Senior VP-Research & Clinical Development
Karen L. Smith MD, PhD482015Chief Medical Officer & Global Head-Research
Paul Treacy55-Senior Vice President-Technical Operations
Paul L. Berns492010Independent Director
Patrick G. Enright, MBA542012Independent Director
Seamus C. Mulligan552012Director
Ken W. O'Keefe, MBA492012Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 60,532,109 59,105,097 97.6% 0 0.0% 97.6%
Shareholders
NameEquities%
Fidelity Management & Research Co. 8,514,518 14.1%
Putnam Investment Management LLC 8,044,558 13.3%
The Vanguard Group, Inc. 4,217,908 6.97%
BlackRock Fund Advisors 2,060,980 3.41%
FIL Investment Advisors (UK) Ltd 1,798,540 2.97%
Westfield Capital Management Co. LP 1,784,762 2.95%
Seamus C. Mulligan 1,075,976 1.78%
Janus Capital Management LLC 989,848 1.64%
SSgA Funds Management, Inc. 830,562 1.37%
Cadian Capital Management LP 764,236 1.26%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Specialty & Advanced Pharmaceuticals
Advertisement
Sector Specialty & Advanced Pharmaceuticals
1st jan.Capitalization (M$)
JAZZ PHARMACEUTICALS P..-8.57%7 780
ABBVIE INC9.06%105 220
BIOGEN INC0.59%67 526
MERCK KGAA8.23%13 807
KYOWA HAKKO KIRIN CO L..-24.83%8 104
MALLINCKRODT PLC0.39%8 070
ZHANGZHOU PIENTZEHUANG..5.84%4 390
YUHAN CORPORATION--.--%3 028
INDIVIOR PLC67.47%2 989
MAYNE PHARMA GROUP LTD36.17%2 210
THERAPEUTICSMD INC-36.26%1 354
ADVANCED ACCELERATOR A..--.--%1 306
SUPERNUS PHARMACEUTICA..64.21%1 093
REPLIGEN CORPORATION10.82%1 059
NICHI-IKO PHARMACEUTIC..-38.82%1 058
LG LIFE SCIENCES, LTD--.--%1 025
EAGLE PHARMACEUTICALS ..-32.07%942
KNIGHT THERAPEUTICS IN..10.65%870
DONG-A ST CO LTD--.--%821
RECIPHARM PUBL AB16.63%774
AIMMUNE THERAPEUTICS I..-20.38%621
Sector Specialty & Advanced Pharmaceuticals
Jazz Pharmaceuticals PLC : Connections
Orbus Therapeutics, Inc.
Circ Pharma Ltd.
Raven Biotechnologies, Inc.
Longitude Capital Management Co. LLC
Vascular Cures
Nueva School
SutroVax, Inc.
Stanford Health Care
Aptinyx, Inc.
InfaCare Pharmaceutical Corp.
Adapt Pharma Ltd.
Xanodyne Pharmaceuticals, Inc.
Beecken Petty O'Keefe & Co. LP
Company contact information
Jazz Pharmaceuticals Plc
Connaught House
One Burlington Road
4th Floor
Dublin 4

Phone : +353.1.634.7800
Fax : +353.1.634.7850
Web : www.jazzpharma.com
© 2016 People , Fundamentals and Ownership